1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Tachycardia, Ventricular

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Tachycardia, Ventricular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inada, M; Iwasaka, T; Izuoka, T; Kimura, Y; Kitashiro, S; Tamura, K; Tamura, T; Tsuji, H	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Tachycardia, Ventricular

Article	Year
The effect of platelet-activating-factor antagonist TCV-309 on arrhythmias and functional recovery during myocardial reperfusion. Coronary artery disease, 1994, Volume: 5, Issue:3 Topics: Action Potentials; Animals; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Isoquinolines; Myocardial Contraction; Myocardial Reperfusion Injury; Platelet Activating Factor; Pyridinium Compounds; Tachycardia, Ventricular; Tetrahydroisoquinolines; Ventricular Fibrillation; Ventricular Function, Left	1994

Article

Year

The effect of platelet-activating-factor antagonist TCV-309 on arrhythmias and functional recovery during myocardial reperfusion.

Coronary artery disease, 1994, Volume: 5, Issue:3

Topics: Action Potentials; Animals; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Isoquinolines; Myocardial Contraction; Myocardial Reperfusion Injury; Platelet Activating Factor; Pyridinium Compounds; Tachycardia, Ventricular; Tetrahydroisoquinolines; Ventricular Fibrillation; Ventricular Function, Left

1994